Skip to main content

Bausch & Lomb Corp

For the period ended Dec 31, 2024. Filed Feb 19, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 19, 2025

BLCO$21.37+2.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 2. Properties

We own and lease a number of important properties. Our headquarters are located in Vaughan, Ontario, Canada. We own several manufacturing facilities throughout the United States. We also own or have an interest in manufacturing plants or other properties outside the United States, including in Mexico, and certain countries in Europe, the Middle East, Asia and South America.

We consider our facilities to be in satisfactory condition and suitable for their intended use, although some limited investments to improve our manufacturing and other related facilities are contemplated, based on the needs and requirements of our business. Our administrative, marketing, research/laboratory, distribution and warehousing facilities are located in various parts of the world. We co-locate our R&D activities with our manufacturing at the plant level in a number of facilities. Our scientists, engineers, quality assurance/quality control professionals and manufacturing technicians work side-by-side in designing and manufacturing products that fit the needs and requirements of our customers, regulators and business units. We believe that we have sufficient facilities to conduct our operations. The following are our principal properties, including the segments of our business that use each property:

LocationPurposeSegmentOwnedorLeasedApproximateSquareFootage
Vaughan, Ontario, CanadaCorporate headquarters and distribution facilityAll SegmentsLeased66,000
Bridgewater, New JerseyAdministration shared with BHCAll SegmentsLeased310,000
Rochester, New YorkOffices, R&D and manufacturing facilityPharmaceuticals + Vision CareOwned953,000
Waterford, IrelandR&D and manufacturing facilityVision CareOwned500,000
Woodruff, South CarolinaDistribution facilityVision CareLeased432,000
Jinan, ChinaOffices and manufacturing facilityPharmaceuticals + Vision CareOwned418,000
Berlin, GermanyR&D, manufacturing, distribution and office facilityPharmaceuticalsOwned339,000
Greenville, South CarolinaManufacturing facilityVision CareOwned314,000
Lynchburg, VirginiaOffices and distribution facilityVision CareOwned224,000
Aubenas, FranceOffices, manufacturing and warehouse facilityPharmaceuticalsOwned193,000
Tampa, FloridaR&D and manufacturing facilityPharmaceuticalsOwned171,000
St. Louis, MissouriOffices, R&D and manufacturing facilitySurgicalOwned140,000
Macherio, ItalyOffices, manufacturing and warehouse facilityVision CareOwned119,000
Clearwater, FloridaR&D and manufacturing facilitySurgicalOwned102,000
Beijing, ChinaManufacturing facilityVision CareOwned97,000
Eppelheim, GermanyManufacturing facilitySurgicalLeased78,000
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.